rss
J Clin Pathol 2008;61:347-351 doi:10.1136/jcp.2006.037093
  • Original article

The role of a recombinant hybrid protein based ELISA for the serodiagnosis of Onchocerca volvulus

  1. J A Andrews1,
  2. W J Bligh1,
  3. P L Chiodini1,
  4. J E Bradley2,
  5. P N Nde3,
  6. R Lucius4
  1. 1
    Department of Clinical Parasitology, The Hospital for Tropical Diseases, Mortimer Market, London WC1E 6AU, UK
  2. 2
    Department of Parasitology, University of Nottingham, Nottingham, UK
  3. 3
    Department of Microbial Pathogenesis and Immune Response, Meharry Medical College, Nashville, Tennessee, USA
  4. 4
    Department of Molecular Parasitology, Humboldt University, Berlin, Germany
  1. Dr Julie Andrews, 9 The Deerings, Harpenden AL5 2PF, UK; julie.andrews{at}whittington.nhs.uk
  • Accepted 21 September 2007
  • Published Online First 8 October 2007

Abstract

Aims: Onchocerca volvulus infection is traditionally diagnosed by examination of skin snips for the presence of microfilariae. A disadvantage of this method is the low sensitivity particularly with light or prepatent infection. Serodiagnosis using recombinant-antigen-based assays may provide a more sensitive diagnostic test. An ELISA based on a recombinant antigen OvH3 has previously been validated using sera from endemic areas. This study investigated the role of this ELISA-based assay for use in the serodiagnosis of onchocerciasis in non-endemic areas.

Methods: The ELISA-based assay was tested on sera from untreated patients with known onchocerciasis and on untreated and treated patients with definite or probable onchocerciasis identified from a hospital diagnostic database. The assay was also tested on sera from patients with other helminthic infections to determine the sensitivity and specificity of this assay in a tertiary referral laboratory dealing with sera from a variety of patients.

Results: The sensitivity and specificity of the OvH3 assay were 93.2% and 93.5%, respectively, when tested on non-endemic patients with clinical diagnosis of onchocerciasis.

Conclusions: This study demonstrates the potential role of the assay as a sensitive and specific test for use in the serodiagnosis of onchocerciasis in a reference laboratory dealing with sera from patients in non-endemic setting.

Footnotes

  • Competing interests: None.

  • Ethics approval: Full ethical approval for this study was obtained from the joint UCL/UCLH committee on the ethics of human research.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. jcp.2006.037093v1
    2. 61/3/347 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.